Abstract
The main aims of international registries for rare diseases are to evaluate genetic and epidemiological features, clinical presentations, treatment, outcome and prognostic factors. In 2008, the Pediatric Rheumatology European Society (PReS) promoted the Eurofever Project, specifically aimed at the creation of a permanent network for the study of autoinflammatory diseases in childhood. The Eurofever Project involved more than 400 centers in 60 countries worldwide; enrollment started in November 2009. In its first version, Eurofever was established as a cross-sectional registry, collecting information of the patients from disease onset to disease diagnosis. In 2015, it was transformed to a longitudinal registry, collecting information on a yearly basis on the clinical evolution and the efficacy and safety of different treatments used in these rare conditions. The first aim of the Eurofever registry was to improve the knowledge about the presentation, disease course, complications, genotype-phenotype correlations and response to treatment of these rare disorders. Further purposes of the Eurofever registry were to generate evidence-based diagnostic and classification criteria and to elaborate on disease activity parameters. During the last 8 years, the international effort to build a common registry on autoinflammatory diseases led to considerable accumulation of new information enabling to fulfill most of the initial aims.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ADDI:
-
Autoinflammatory Disease Damage Index
- AIDAI:
-
Autoinflammatory Disease Activity Index
- CANDLE:
-
Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature
- CAPS:
-
Cryopyrin-associated periodic syndromes
- CARD:
-
Caspase activation and recruitment domain
- CNO:
-
Chronic non-bacterial osteomyelitis
- CRF:
-
Case report form
- DADA2:
-
Deficiency of adenosine deaminase 2
- DIRA:
-
Deficiency of the interleukin-1 receptor antagonist
- DITRA:
-
Deficiency of the interleukin-36 receptor antagonist
- ESID:
-
European Society of Immune-Deficiencies
- EULAR:
-
European League Against Rheumatism
- FCAS2:
-
Familial cold autoinflammatory syndrome 2
- FMF:
-
Familial Mediterranean fever
- HRF:
-
Hereditary recurrent fever
- IL:
-
Interleukin
- ISSAID:
-
International Society of Systemic Autoinflammatory Diseases
- MKD:
-
Mevalonate kinase deficiency
- NLRP:
-
Nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain
- NSAIDs:
-
Nonsteroidal anti-inflammatory drugs
- PAPA:
-
Pyogenic arthritis, pyoderma gangrenosum, acne
- PFAPA:
-
Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis
- PI:
-
Principal investigator
- PReS:
-
Pediatric Rheumatology European Society
- ROC:
-
Receiver operating characteristic
- SAVI:
-
STING-associated vasculopathy with onset in infancy
- SOBI:
-
Swedish Orphan Biovitrum
- TRAPS:
-
Tumor necrosis factor receptor-associated periodic syndrome
References
Ozen S, Frenkel J, Ruperto N. M Gattorno on behalf of the Eurofever Project. The Eurofever project: towards better care for autoinflammatory diseases. Eur J Pediatr. 2011;170:445–52.
Ben Chetrit E, Touitout I. Familial Mediterranean fever in the world. Arthritis Rheum. 2009;61:1447–53.
van der Hilst JC, Bodar EJ, Barron KS, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore). 2008;87:301–10.
Hofer MF, Pillet P, Berg S, et al. International PFAPA syndrome registry: cohort of 214 patients. From 15th Paediatric Rheumatology European Society (PreS) Congress London, UK. 14–17 September 2008.
Hofer M, Pillet P, Cochard MM, et al. International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients. Rheumatology. 2014;53:1125–9.
Koné-Paut I, Darce-Bello M, Shahram F, et al. Registries in rheumatological and musculoskeletal conditions. Paediatric Behcet’s disease: an international cohort study of 110 patients. One-year follow-up data. Rheumatology. 2011;50:184–8.
Koné-Paut I, Shahram F, Darce-Bello M, et al. Consensus classification criteria for paediatric Behçet’s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016;75:958–64.
Rosé CD, Aróstegui JI, Martin TM, et al. NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain. Arthritis Rheum. 2009;60:1797–803.
Rosé CD, Pans S, Casteels I, et al. Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatology (Oxford). 2015;54:1008–16.
Jeske M, Lohse P, Kallinich T, et al. Genotype-phenotype and genotype-origin correlations in children with Mediterranean fever in Germany—an AID-net study. Klin Padiatr. 2013;225:325–30.
Jaeger VK, Hoffman HM, van der Poll T, et al. Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study. Rheumatology (Oxford). 2017;56:1484–91.
Toplak N, Frenkel J, Ozen S, et al. An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis. 2012;71:1177–82.
Ruperto N, Martini A. Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO). Arch Dis Child. 2011;96:596–601.
Gattorno M, Sormani MP, D’Osualdo A, et al. A diagnostic score for molecular analysis of hereditary autoinflmmatory syndromes with periodic fever in children. Arthritis Rheum. 2008;58:1823–32.
Simon A, van der Meer JW, Vasely R, et al. Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes. Rheumatology. 2006;45:269–73.
The French FMF consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25–31.
Ozen S, Demirkaya E, Amaryan G, et al. Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis. 2014;73:662–7.
Levy R, Gérard L, Kuemmerle-Deschner J, et al. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry. Ann Rheum Dis. 2015;74:2043–9.
Lachmann HJ, Papa R, Gerhold K, et al. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. Ann Rheum Dis. 2014;73:2160–7.
ter Haar NM, Jeyaratnam J, Lachmann HJ, et al. The phenotype and genotype of mevalonate kinase deficiency a series of 114 cases from the Eurofever registry. Arthritis Rheumatol. 2016;68:2795–805.
Girschick H, Finetti M, Orlando F, et al. The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry. Rheumatology (Oxford). 2018;57:1203–11.
Papa R, Doglio M, Lachmann H, et al. A web-based collection of genotype phenotype associations in hereditary recurrent fevers from the Eurofever registry. Orphanet J Rare Dis. 2017;12:167.
Livneh A, P Langevitz D, Zaks N, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–85.
Yalcınkaya F, Ozen S, Birsin Ozcakar Z, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology. 2009;48:395–8.
Demirkaya E, Saglam C, Turker T, et al. Performance of different diagnostic criteria for familial Mediterranean fever in children with periodic fevers: results from a multicenter international registry. J Rheumatol. 2016;43:154–60.
Federici S, Sormani MP, Ozen S, et al. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis. 2015;74:799–80.
Shinar Y, Obici L, Aksentijevich I, et al. Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis. 2012;71:1599–605.
Milhavet F, Cuisset L, Hoffman HM, et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat. 2008;29:803–8.
Thomas KT, Feder HM, Lawton AR, et al. Periodic fever syndrome in children. J Pediatr. 1999;135:15–21.
Piram M, Koné-Paut I, Lachmann HJ, et al. Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes. Ann Rheum Dis. 2014;73:2168–73.
Ter Haar NM, Annik KV, Al-Mayouf SM, et al. Development of the autoinflammatory disease damage index (ADDI). Ann Rheum Dis. 2017;76:821–30.
Ter Haar N, Lachmann H, Özen S, et al. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis. 2013;72:678–85.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Finetti, M., Gattorno, M. (2019). The Role of International Registries for Rare Autoinflammatory Diseases. In: Hashkes, P., Laxer, R., Simon, A. (eds) Textbook of Autoinflammation. Springer, Cham. https://doi.org/10.1007/978-3-319-98605-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-98605-0_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98604-3
Online ISBN: 978-3-319-98605-0
eBook Packages: MedicineMedicine (R0)